Abiopharma

New Form 8-K - Passage BIO, Inc. Filed: 2025-08-12 AccNo: 0001558370-25-011143 Size: 5 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits